CAMBRIDGE, Mass. (AP) _ Editas Medicine Inc. (EDIT) on Wednesday reported a loss of $56.7 million in its first quarter.

The Cambridge, Massachusetts-based company said it had a loss of 86 cents per share.

The results did not meet Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of 76 cents per share.

The genome editing company posted revenue of $6.5 million in the period, which beat Street forecasts. Four analysts surveyed by Zacks expected $6.3 million.

Editas shares have decreased 51% since the beginning of the year. The stock has risen 39% in the last 12 months.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on EDIT at https://www.zacks.com/ap/EDIT

Copyright by Automated Insights, Inc. All rights reserved., source Associated Press News